Renaissance Technologies’s Titan Pharmaceuticals TTNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $47.8K | Buy |
+11,380
| New | +$47.8K | ﹤0.01% | 3398 |
|
2024
Q4 | – | Sell |
-11,066
| Closed | -$58.3K | – | 3923 |
|
2024
Q3 | $58.3K | Buy |
+11,066
| New | +$58.3K | ﹤0.01% | 3329 |
|
2024
Q1 | – | Sell |
-6,766
| Closed | -$56K | – | 4091 |
|
2023
Q4 | $56K | Sell |
6,766
-20
| -0.3% | -$166 | ﹤0.01% | 3435 |
|
2023
Q3 | $64K | Buy |
6,786
+5
| +0.1% | +$47 | ﹤0.01% | 3350 |
|
2023
Q2 | $88K | Buy |
6,781
+10
| +0.1% | +$130 | ﹤0.01% | 3505 |
|
2023
Q1 | $112K | Buy |
6,771
+50
| +0.7% | +$827 | ﹤0.01% | 3457 |
|
2022
Q4 | $105K | Sell |
6,721
-515
| -7% | -$8.05K | ﹤0.01% | 3602 |
|
2022
Q3 | $156K | Sell |
7,236
-4,800
| -40% | -$103K | ﹤0.01% | 3461 |
|
2022
Q2 | $135K | Buy |
12,036
+10,210
| +559% | +$115K | ﹤0.01% | 3764 |
|
2022
Q1 | $35K | Buy |
1,826
+850
| +87% | +$16.3K | ﹤0.01% | 3954 |
|
2021
Q4 | $20K | Buy |
976
+326
| +50% | +$6.68K | ﹤0.01% | 3839 |
|
2021
Q3 | $24K | Buy |
+650
| New | +$24K | ﹤0.01% | 3405 |
|
2020
Q1 | – | Sell |
-534
| Closed | -$62K | – | 3801 |
|
2019
Q4 | $62K | Buy |
+534
| New | +$62K | ﹤0.01% | 3374 |
|
2019
Q1 | – | Sell |
-72
| Closed | -$58K | – | 3704 |
|
2018
Q4 | $58K | Sell |
72
-124
| -63% | -$99.9K | ﹤0.01% | 3281 |
|
2018
Q3 | $146K | Buy |
196
+16
| +9% | +$11.9K | ﹤0.01% | 3204 |
|
2018
Q2 | $707K | Buy |
180
+13
| +8% | +$51.1K | ﹤0.01% | 2724 |
|
2018
Q1 | $632K | Buy |
167
+14
| +9% | +$53K | ﹤0.01% | 2835 |
|
2017
Q4 | $732K | Buy |
153
+31
| +25% | +$148K | ﹤0.01% | 2783 |
|
2017
Q3 | $771K | Buy |
122
+45
| +58% | +$284K | ﹤0.01% | 2666 |
|
2017
Q2 | $530K | Buy |
77
+11
| +17% | +$75.7K | ﹤0.01% | 2747 |
|
2017
Q1 | $781K | Buy |
66
+25
| +61% | +$296K | ﹤0.01% | 2628 |
|
2016
Q4 | $586K | Buy |
+41
| New | +$586K | ﹤0.01% | 2725 |
|
2016
Q1 | – | Sell |
-17
| Closed | -$275K | – | 3534 |
|
2015
Q4 | $275K | Buy |
+17
| New | +$275K | ﹤0.01% | 2910 |
|